Author Correction: DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B
作者更正：DKN-01 和替雷利珠单抗作为 DKK1 高表达胃食管腺癌二线治疗：DisTinGuish 试验 B 部分
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-69394-0
Lee, Keun-Wook; Mahalingam, Devalingam; Shim, Byoung Yong; Kim, In-Ho; Oh, Do-Youn; Uronis, Hope; Sym, Sun Jin; Sonbol, Mohamad; Almhanna, Khaldoun; Tejani, Mohamedtaki A; Kang, Beodeul; Kagey, Michael H; Stilian, Melissa; Jia, Calvin; Sirard, Cynthia A; Altura, Rachel; Ajani, Jaffer A; Klempner, Samuel J
